Allergan defends JUVEDERM® patents against nine IPR petitions filed by Prollenium
Clients Allergan, Inc.
Jones Day is representing Allergan, Inc. before the U.S. Patent Trial and Appeal Board ("PTAB") on nine IPR petitions filed by Prollenium challenging multiple patents covering certain of Allergan's JUVEDERM® products, hyaluronic acid-based dermal fillers that include the anesthetic lidocaine.
Prollenium US Inc., et al. v. Allergan Industrie SAS, et al., IPR Nos. 2019-01505, -01506, -01508, -01509, -01617, -01632; 2020-00084, -00901, -00902 (PTAB)